Radiological and clinical improvement in a patient with COVID-19 pneumonia postconvalescent plasma transfusion: A case report

Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). Convalescent plasma has not yet been approved for use in patients with COVID19 infection; however, it is regulated as an investigational product. This is a case report of a 55-year-old male, wit...

Full description

Autores:

Tipo de recurso:

Article of investigation

Fecha de publicación:

2020

Institución:

Universidad de Bogotá Jorge Tadeo Lozano

Repositorio:

Expeditio: repositorio UTadeo

Idioma:

eng

OAI Identifier:

oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/13581

Acceso en línea:

https://doi.org/10.1016/j.radcr.2020.07.031
http://hdl.handle.net/20.500.12010/13581

Palabra clave:

COVID-19
RT-PCR
Convalescent plasma transfusion
Groung-glass opacities
Crazy paving appearance
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus

Rights

License

Abierto (Texto Completo)